Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Cell And Gene Therapy Supply Chain/Logistics Market Size Shifted, And What Is the Outlook Through 2034?
In the past few years, the market size for the cell and gene therapy supply chain/logistics has seen considerable expansion. It is forecasted to surge from $1.41 billion in 2024 to $1.57 billion in 2025, with a compound annual growth rate (CAGR) of 11.5%. Factors contributing to this significant increase during the historic period include heightened prevalence of chronic illnesses, enhanced utilization of supply chain necessities, a rise in preserving drug integrity, advancements in regulatory frameworks, and a greater focus on risk reduction and adherence to regulations.
The market for cell and gene therapy supply chain/logistics is set to see a profound expansion in the upcoming years. The current projection places it at a value of$2.44 billion by 2029″, expanding at a Compound Annual Growth Rate (CAGR) of 11.5%. The predicted growth over the forecast period is largely due to a surge in personalized medicine, the rise of cell-free therapies, increasing incidence of chronic diseases, expansion of the global cell therapy manufacturing market, and effective supply chain management. Further fuelling this growth are trends such as enhanced research and development expenditure, adoption of groundbreaking technologies, favorable initiatives for easier access, strategic partnerships and collaborations among cell and gene therapy organizations, supply chain entities, and logistics firms, as well as the offer of customizable services to assist at all stages of patient identification.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp
Which Primay Drivers Are Accelerating Growth in the Cell And Gene Therapy Supply Chain/Logistics Market?
The escalating demand for cell and gene treatments is propelling the growth of the cell and gene therapy supply chain, also known as the logistics market. These progressive medical treatments, which alter cells or genes to address diseases, offer potential major advancements for conditions previously deemed untreatable. Ensuring these therapies are stored properly, at the right temperature and under the correct conditions, is imperative and can be managed through supply chain and logistics services. These services aid in sourcing, distributing, and securing storage for these therapies. For instance, data from the American Society of Gene & Cell Therapy, a non-profit U.S. medical and scientific organization, showed that gene therapies in Phase III clinical trials surged by 10% in Q3 2023 – the first quarterly growth since Q3 2022. Hence, the escalating demand for cell and gene therapies is what propels the cell and gene therapy supply chain or logistics market ahead.
Which Primary Segments of the Cell And Gene Therapy Supply Chain/Logistics Market Are Driving Growth and Industry Transformations?
The cell and gene therapy supply chain/logisticsmarket covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform; Enterprise Manufacturing System; Inventory Management System; Laboratory Information Management System; Logistics Management System; Patient Management System; Quality Management System; Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution; On-Premises Solution
3) By Component: Cryogenic Shippers; Cryogenic Storage Freezers; Ultra-Low Freezers; Cold Chain Management Systems; Shipment; Storage Medium; Cryogenic Packout Kits; Other Components
4) By Application Area: Donor Eligibility Assessment; Sample Collection; Manufacturing; Logistics; Patient Verification; Treatment Follow-Up
5) By End User: Biobank; Cell Therapy Lab; Hospital; Research Institute; Commercial Organization
Subsegments:
1) By Cell Orchestration Platform: Workflow Management; Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control; Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management; Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management; Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning; Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination; Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking; Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments; Chain Of Custody Documentation
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12631&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cell And Gene Therapy Supply Chain/Logistics Market?# Market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Technological Trends Are Reshaping the Cell And Gene Therapy Supply Chain/Logistics Industry Dynamics?
In the cell and gene therapy supply chain/logistics markets, a primary trend gaining traction is the use of modern technology platforms. To maintain their market stronghold, major corporations in this market are establishing these advanced technological systems for cell and gene therapies. For example, AmerisourceBergen Corporation, a leading U.S healthcare company with a particular focus on cell and gene therapy supply chain logistics, introduced the Cell and Gene Therapy (CGT) Integration Hub in April 2023. This integration hub relies on AmerisourceBergen’s cutting-edge customer relationship management (CRM) system and can be amalgamated into the biopharma platform, undoubtedly improving the way the development and delivery of cell and gene therapies are overseen.
View the full report here:
What Parameters Are Used to Define the Cell And Gene Therapy Supply Chain/Logistics Market?
Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12631
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
